RGNX Aligns with FDA
REGENXBIO announces alignment with FDA on path forward for NAVSUNLI BLA resubmission for accelerated approval
RGNX - REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS II